Find your next paid study

University of MiamiNCT07789912

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of LYL273 in Patients With Relapsed or Refractory Metastatic Colorectal Cancer

This is a Phase 1/2 open-label, multicenter study evaluating the safety and efficacy of LYL273 in participants with relapsed or refractory metastatic colorecta…

Colorectal Cancer

Lyell Immunopharma, Inc.NCT05319314

~$150 – $4,200

Actual pay is set by the research site.

Doula SupportPostpartumPostpartum Depression (PPD)+1 more

Nurturing, Empowering, Supporting Together (NEST): a Project to Improve Postpartum Birth Outcomes in the NICU.

The primary objective of this research is to conduct a randomized clinical trial to examine the impact of nurse-coordinated, doula-delivered postpartum support…

University of South CarolinaNCT07787845

Actual pay is set by the research site.

MObile Health Intervention to INcrease Activity in Heart Failure Study: A Micro-Randomized Trial

Physical activity is known to help patients with heart failure feel better and live longer though few patients with heart failure are sufficiently active. This…

Heart Failure

University of MichiganNCT07750262

Actual pay is set by the research site.

Ultrasound Assessment of Gastric Volume After Drinking Premedication: A Prospective Descriptive Study

The primary objective of this study is to assess gastric volume in fasted children using ultrasound before and after drinking premedication. The hypothesis is …

Surgery

Kevin SpellmanNCT04130022

~$10 – $1,125

Actual pay is set by the research site.

Tobacco ProductsCigarettesElectronic Cigarettes

Designing and Evaluating Communication for Dual Users of E-cigarettes and Combustible Cigarettes

The study is a pilot test of effectiveness of communication campaign ads on interest in quitting combustible cigarettes and e-cigarettes. Over the course of 5 …

UNC Lineberger Comprehensive Cancer CenterNCT07599462

Actual pay is set by the research site.

Myelodysplastic Syndromes

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion-Dependent Anemia in Adult Participants With Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) (RENEW)

The main aim of this study is to find out how well elritercept works in lowering the need for RBC transfusions. Other aims are to learn how well elritercept wo…

~$50 – $2,250

Actual pay is set by the research site.

TakedaNCT06499285

Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS)

This study will collect information from patients with Alagille syndrome (ALGS) as they use odevixibat (Bylvay) in their daily lives. Odevixibat is a medicine…

Alagille Syndrome

~$10 – $1,125

Actual pay is set by the research site.

IpsenNCT06850038

Autosomal Recessive Polycystic Kidney (ARPKD)

A Phase 3b Multicenter Open-label Trial of the Safety, Tolerability, and Efficacy of Tolvaptan in Infants and Children 28 Days to Less Than 18 Years of Age With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

To evaluate the pharmacodynamics and safety of tolvaptan in pediatric subjects with ARPKD

Otsuka Pharmaceutical Development & Commercialization, Inc.NCT04782258

~$50 – $2,100

Actual pay is set by the research site.

Primary Sclerosing Cholangitis

A Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis

The purpose of this study is to find out how well and safely elafibranor works compared to placebo in adult participants with Primary sclerosing cholangitis (P…

~$50 – $2,250

Actual pay is set by the research site.

IpsenNCT07387549

ReadmissionReadmission RatesReadmission, Hospital+1 more

A Clinician-Patient Dual Behavior Change Framework to Leverage Informed Digital Nudges to Reduce Hospital Readmissions and Improve Patient Outcomes: A Randomized Trial for Scalable Strategy to Reduce Readmissions (PREVENT-R)

The PREVENT-R trial will evaluate an intervention targeting both clinician and patient behavior. The clinician-focused piece consists of an electronic medical …

Yale UniversityNCT07890961

Actual pay is set by the research site.

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy

Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of proteins (called immune complexes) that b…

Kidney Disease